AMS Diagnostics is a leading group with focus in Healthcare & Medical Diagnostics. The company's slogan is indicative of its core business, emphasizing a commitment to advancing healthcare through diagnostic solutions.
The company's value proposition lies in its clinical chemistry offerings for physician laboratory offices. The Liasys Clinical Chemistry Systems sets itself apart with capabilities to conduct 330 and 450 tests per hour. Additionally, its quality control monitored durable cuvette washing system and enhanced operator graphic interface promise exceptional value without compromising the precision and accuracy expected in medical diagnostics.
Based in the United States, the company appeals to investors interested in the healthcare and medical technology industry. However, specific details regarding founding date, past investments, and investors are not currently provided, which may warrant further investigation for potential venture capital opportunities.